Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease

被引:10
|
作者
Tommasi, Nicole S. [1 ,2 ]
Gonzalez, Christopher [1 ,2 ,3 ]
Briggs, Danielle [1 ,2 ,3 ]
Properzi, Michael J. [3 ]
Gatchel, Jennifer R. [4 ,5 ]
Marshall, Gad A. [1 ,2 ,3 ]
机构
[1] Harvard Med Sch, Ctr Alzheimer Res & Treatment, Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Neurol, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Harvard Med Sch, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA
[5] Harvard Med Sch, Div Geriatr Psychiat, McLean Hosp, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
affective symptoms; Alzheimer' s disease; amyloid; mild cognitive impairment; neuropsychiatric symptoms; positron emission tomography; tau; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHIATRIC SYMPTOMS; INSTRUMENTAL ACTIVITIES; AMYLOID-BETA; APATHY; ACCUMULATION; PROGRESSION; INVENTORY; DEMENTIA; PSYCHOPATHOLOGY;
D O I
10.1002/gps.5530
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective Neuropsychiatric symptoms (NPS) are often present in individuals with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia. NPS are associated with structural and functional changes in the brain such as atrophy, regional hypometabolism, and hypoperfusion, considered proxies of neurodegeneration. Our objective was to evaluate the association between NPS and regional cerebral tau burden, a more direct representation of neurodegeneration, in cognitively normal (CN), MCI, and AD dementia individuals. Methods Cross-sectional NPS were assessed using the Neuropsychiatric Inventory (NPI) in 410 CN, 199 MCI, and 61 AD dementia participants who underwent flortaucipir tau positron emission tomography as part of the AD Neuroimaging Initiative (ADNI). Total NPI score and two factors of NPS (affective and hyperactive) were used in analyses. Linear regression models with backward elimination were employed with NPI as dependent variable and regional tau or tau-amyloid interaction as predictor of interest. Covariates included education, age, sex, Rey Auditory Verbal Learning Test Total Learning, and Trail Making Test B. Results There were significant associations (p < 0.05) between the NPI variables (total score, Affective factor) and entorhinal and precuneus tau across all participants. These associations were also significant for the tau-amyloid interaction. These effects were significant in cognitively symptomatic participants (MCI and AD dementia), but not in CN participants. Conclusions Increased tau burden in the entorhinal and precuneus cortices was modestly associated with greater NPS in MCI and AD dementia. Further evaluation of NPS and their effect on early-stage AD could aid in finding new interventions and slowing disease progression.
引用
收藏
页码:1050 / 1058
页数:9
相关论文
共 50 条
  • [31] Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI
    Yan, Tianyi
    Wang, Yonghao
    Weng, Zizheng
    Du, Wenying
    Liu, Tiantian
    Chen, Duanduan
    Li, Xuesong
    Wu, Jinglong
    Han, Ying
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 68 (03) : 1013 - 1027
  • [32] Self-Regulation of Driving Behaviors in Persons With Early-Stage Alzheimer's Disease
    Davis, Rebecca
    Owens, Megan
    JOURNAL OF GERONTOLOGICAL NURSING, 2021, 47 (01): : 21 - 27
  • [33] Neuropsychiatric symptoms are early indicators of an upcoming metabolic decline in Alzheimer's disease
    Ng, Kok Pin
    Pascoal, Tharick A.
    Mathotaarachchi, Sulantha
    Chan, Yiong Huak
    Jiang, Lai
    Therriault, Joseph
    Benedet, Andrea L.
    Shin, Monica
    Kandiah, Nagaendran
    Greenwood, Celia M. T.
    Rosa-Neto, Pedro
    Gauthier, Serge
    Network, Dominantly Inherited Alzheimer
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [34] Locomotor Hyperactivity in the Early-Stage Alzheimer's Disease-like Pathology of APP/PS1 Mice: Associated with Impaired Polarization of Astrocyte Aquaporin 4
    Wang, Tianqi
    Chen, Yan
    Zou, Ying
    Pang, Yingting
    He, Xiaoxin
    Chen, Yali
    Liu, Yun
    Feng, Weixi
    Zhang, Yanli
    Li, Qian
    Shi, Jingping
    Ding, Fengfei
    Marshall, Charles
    Gao, Junying
    Xiao, Ming
    AGING AND DISEASE, 2022, 13 (05): : 1504 - 1522
  • [35] Regulatory Innovation and Drug Development for Early-Stage Alzheimer's Disease
    Kozauer, Nicholas
    Katz, Russell
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13) : 1169 - 1171
  • [36] Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review
    Banning, Leonie C. P.
    Ramakers, Inez H. G. B.
    Deckers, Kay
    Verhey, Frans R. J.
    Aalten, Pauline
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2019, 107 : 346 - 359
  • [37] Neuropsychiatric Profile in Early Versus Late Onset Alzheimer's Disease
    Ferreira, Maria do Ceu
    Abreu, Maria Joao
    Machado, Celia
    Santos, Beatriz
    Machado, Alvaro
    Costa, Ana Sofia
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2018, 33 (02): : 93 - 99
  • [38] Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression
    Tok, Sean
    Ahnaou, Abdallah
    Drinkenburg, Wilhelmus
    JOURNAL OF ALZHEIMERS DISEASE, 2022, 88 (03) : 809 - 836
  • [39] The Role of Dopamine in Symptoms and Treatment of Apathy in Alzheimer's Disease
    Mitchell, Robert A.
    Herrmann, Nathan
    Lanctot, Krista L.
    CNS NEUROSCIENCE & THERAPEUTICS, 2011, 17 (05) : 411 - 427
  • [40] Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease
    Davis, Marie-Claire
    Hill, Aron T.
    Fitzgerald, Paul B.
    Bailey, Neil W.
    Stout, Julie C.
    Hoy, Kate E.
    CLINICAL NEUROPHYSIOLOGY, 2023, 153 : 166 - 176